カテゴリ： Market Monitor Global, 世界, 医療/バイオ

遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル市場展望 2023年-2029年：血清型2（AVV2）、合成血清型、その他

■ 英語タイトル：Adeno-Associated Virus Vectors in Gene Therapy Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU4946）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU4946
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：76
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル市場展望 2023年-2029年：血清型2（AVV2）、合成血清型、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場規模と予測を収録しています。・世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：売上、2018年-2023年、2024年-2029年
・世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「血清型2（AVV2）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル主要企業は、Amicus Therapeutics、 Asklepios Biopharmaceutical、 BioMarin Pharmaceutical、 Coave Therapeutics、 MeiraGTx、 Neurocrine Biosciences、 Pfizer、 Roche Holding、 Sangamo Therapeutics、 Sarepta Therapeutics、 Spark Therapeutics、 Voyager Therapeutics、 NightstaRxなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、遺伝子治療におけるアデノ随伴ウイルスベクターのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：タイプ別、2018年-2023年、2024年-2029年
世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：タイプ別市場シェア、2022年
・血清型2（AVV2）、合成血清型、その他

世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：用途別、2018年-2023年、2024年-2029年
世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：用途別市場シェア、2022年
・アルツハイマー病、嚢胞性線維症、血友病B、パーキンソン病

世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：地域・国別、2018年-2023年、2024年-2029年
世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル売上、2018年-2023年
・主要企業における遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル売上シェア、2022年
・主要企業における遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル販売量、2018年-2023年
・主要企業における遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Amicus Therapeutics、 Asklepios Biopharmaceutical、 BioMarin Pharmaceutical、 Coave Therapeutics、 MeiraGTx、 Neurocrine Biosciences、 Pfizer、 Roche Holding、 Sangamo Therapeutics、 Sarepta Therapeutics、 Spark Therapeutics、 Voyager Therapeutics、 NightstaRx

*************************************************************

・調査・分析レポートの概要
遺伝子治療におけるアデノ随伴ウイルスベクター市場の定義
市場セグメント
世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場規模
世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場規模：2022年 VS 2029年
世界の遺伝子治療におけるアデノ随伴ウイルスベクター市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの遺伝子治療におけるアデノ随伴ウイルスベクターの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の遺伝子治療におけるアデノ随伴ウイルスベクター製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：血清型2（AVV2）、合成血清型、その他
遺伝子治療におけるアデノ随伴ウイルスベクターのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：アルツハイマー病、嚢胞性線維症、血友病B、パーキンソン病
遺伝子治療におけるアデノ随伴ウイルスベクターの用途別グローバル売上・予測

・地域別市場分析
地域別遺伝子治療におけるアデノ随伴ウイルスベクター市場規模 2022年と2029年
地域別遺伝子治療におけるアデノ随伴ウイルスベクター売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Amicus Therapeutics、 Asklepios Biopharmaceutical、 BioMarin Pharmaceutical、 Coave Therapeutics、 MeiraGTx、 Neurocrine Biosciences、 Pfizer、 Roche Holding、 Sangamo Therapeutics、 Sarepta Therapeutics、 Spark Therapeutics、 Voyager Therapeutics、 NightstaRx
...

Adeno-associated viruses (AAV) are small viruses that infect humans and some other primate species. They belong to the genus Dependoparvovirus, which in turn belongs to the family Parvoviridae. They are small (20 nm) replication-defective, nonenveloped viruses and have linear single-stranded DNA (ssDNA) genome of approximately 4.8 kilobases (kb).
This report aims to provide a comprehensive presentation of the global market for Adeno-Associated Virus Vectors in Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adeno-Associated Virus Vectors in Gene Therapy. This report contains market size and forecasts of Adeno-Associated Virus Vectors in Gene Therapy in global, including the following market information:
Global Adeno-Associated Virus Vectors in Gene Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Adeno-Associated Virus Vectors in Gene Therapy Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Adeno-Associated Virus Vectors in Gene Therapy companies in 2022 (%)
The global Adeno-Associated Virus Vectors in Gene Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Serotype 2 (AVV 2) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Adeno-Associated Virus Vectors in Gene Therapy include Amicus Therapeutics, Asklepios Biopharmaceutical, BioMarin Pharmaceutical, Coave Therapeutics, MeiraGTx, Neurocrine Biosciences, Pfizer, Roche Holding and Sangamo Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adeno-Associated Virus Vectors in Gene Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adeno-Associated Virus Vectors in Gene Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy Market Segment Percentages, by Type, 2022 (%)
Serotype 2 (AVV 2)
Synthetic Serotypes
Others
Global Adeno-Associated Virus Vectors in Gene Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy Market Segment Percentages, by Application, 2022 (%)
Alzheimer’s Disease
Cystic Dibrosis
Hemophilia B
Parkinson’s Disease
Global Adeno-Associated Virus Vectors in Gene Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adeno-Associated Virus Vectors in Gene Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Adeno-Associated Virus Vectors in Gene Therapy revenues share in global market, 2022 (%)
Key companies Adeno-Associated Virus Vectors in Gene Therapy sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Adeno-Associated Virus Vectors in Gene Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amicus Therapeutics
Asklepios Biopharmaceutical
BioMarin Pharmaceutical
Coave Therapeutics
MeiraGTx
Neurocrine Biosciences
Pfizer
Roche Holding
Sangamo Therapeutics
Sarepta Therapeutics
Spark Therapeutics
Voyager Therapeutics
NightstaRx
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adeno-Associated Virus Vectors in Gene Therapy, market overview.
Chapter 2: Global Adeno-Associated Virus Vectors in Gene Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Adeno-Associated Virus Vectors in Gene Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adeno-Associated Virus Vectors in Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Adeno-Associated Virus Vectors in Gene Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Adeno-Associated Virus Vectors in Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adeno-Associated Virus Vectors in Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adeno-Associated Virus Vectors in Gene Therapy Overall Market Size
2.1 Global Adeno-Associated Virus Vectors in Gene Therapy Market Size: 2022 VS 2029
2.2 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Adeno-Associated Virus Vectors in Gene Therapy Sales: 2018-2029
3 Company Landscape
3.1 Top Adeno-Associated Virus Vectors in Gene Therapy Players in Global Market
3.2 Top Global Adeno-Associated Virus Vectors in Gene Therapy Companies Ranked by Revenue
3.3 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Companies
3.4 Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Companies
3.5 Global Adeno-Associated Virus Vectors in Gene Therapy Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Adeno-Associated Virus Vectors in Gene Therapy Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Adeno-Associated Virus Vectors in Gene Therapy Players in Global Market
3.8.1 List of Global Tier 1 Adeno-Associated Virus Vectors in Gene Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Adeno-Associated Virus Vectors in Gene Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Market Size Markets, 2022 & 2029
4.1.2 Serotype 2 (AVV 2)
4.1.3 Synthetic Serotypes
4.1.4 Others
4.2 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue & Forecasts
4.2.1 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2023
4.2.2 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2024-2029
4.2.3 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
4.3 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Sales & Forecasts
4.3.1 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2023
4.3.2 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2024-2029
4.3.3 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
4.4 By Type – Global Adeno-Associated Virus Vectors in Gene Therapy Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2022 & 2029
5.1.2 Alzheimer’s Disease
5.1.3 Cystic Dibrosis
5.1.4 Hemophilia B
5.1.5 Parkinson’s Disease
5.2 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue & Forecasts
5.2.1 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2023
5.2.2 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2024-2029
5.2.3 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
5.3 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Sales & Forecasts
5.3.1 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2023
5.3.2 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2024-2029
5.3.3 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
5.4 By Application – Global Adeno-Associated Virus Vectors in Gene Therapy Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2022 & 2029
6.2 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue & Forecasts
6.2.1 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2023
6.2.2 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2024-2029
6.2.3 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2018-2029
6.3 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Sales & Forecasts
6.3.1 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2023
6.3.2 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2024-2029
6.3.3 By Region – Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2029
6.4.2 By Country – North America Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2029
6.4.3 US Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.4.4 Canada Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.4.5 Mexico Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2029
6.5.2 By Country – Europe Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2029
6.5.3 Germany Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5.4 France Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5.5 U.K. Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5.6 Italy Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5.7 Russia Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5.8 Nordic Countries Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.5.9 Benelux Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2029
6.6.2 By Region – Asia Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2029
6.6.3 China Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.6.4 Japan Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.6.5 South Korea Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.6.6 Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.6.7 India Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2029
6.7.2 By Country – South America Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2029
6.7.3 Brazil Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.7.4 Argentina Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales, 2018-2029
6.8.3 Turkey Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.8.4 Israel Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.8.5 Saudi Arabia Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
6.8.6 UAE Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amicus Therapeutics
7.1.1 Amicus Therapeutics Company Summary
7.1.2 Amicus Therapeutics Business Overview
7.1.3 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.1.4 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.1.5 Amicus Therapeutics Key News & Latest Developments
7.2 Asklepios Biopharmaceutical
7.2.1 Asklepios Biopharmaceutical Company Summary
7.2.2 Asklepios Biopharmaceutical Business Overview
7.2.3 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.2.4 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.2.5 Asklepios Biopharmaceutical Key News & Latest Developments
7.3 BioMarin Pharmaceutical
7.3.1 BioMarin Pharmaceutical Company Summary
7.3.2 BioMarin Pharmaceutical Business Overview
7.3.3 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.3.4 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.3.5 BioMarin Pharmaceutical Key News & Latest Developments
7.4 Coave Therapeutics
7.4.1 Coave Therapeutics Company Summary
7.4.2 Coave Therapeutics Business Overview
7.4.3 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.4.4 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.4.5 Coave Therapeutics Key News & Latest Developments
7.5 MeiraGTx
7.5.1 MeiraGTx Company Summary
7.5.2 MeiraGTx Business Overview
7.5.3 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.5.4 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.5.5 MeiraGTx Key News & Latest Developments
7.6 Neurocrine Biosciences
7.6.1 Neurocrine Biosciences Company Summary
7.6.2 Neurocrine Biosciences Business Overview
7.6.3 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.6.4 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.6.5 Neurocrine Biosciences Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.7.4 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Roche Holding
7.8.1 Roche Holding Company Summary
7.8.2 Roche Holding Business Overview
7.8.3 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.8.4 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.8.5 Roche Holding Key News & Latest Developments
7.9 Sangamo Therapeutics
7.9.1 Sangamo Therapeutics Company Summary
7.9.2 Sangamo Therapeutics Business Overview
7.9.3 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.9.4 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.9.5 Sangamo Therapeutics Key News & Latest Developments
7.10 Sarepta Therapeutics
7.10.1 Sarepta Therapeutics Company Summary
7.10.2 Sarepta Therapeutics Business Overview
7.10.3 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.10.4 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.10.5 Sarepta Therapeutics Key News & Latest Developments
7.11 Spark Therapeutics
7.11.1 Spark Therapeutics Company Summary
7.11.2 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Business Overview
7.11.3 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.11.4 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.11.5 Spark Therapeutics Key News & Latest Developments
7.12 Voyager Therapeutics
7.12.1 Voyager Therapeutics Company Summary
7.12.2 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Business Overview
7.12.3 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.12.4 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.12.5 Voyager Therapeutics Key News & Latest Developments
7.13 NightstaRx
7.13.1 NightstaRx Company Summary
7.13.2 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Business Overview
7.13.3 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.13.4 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2018-2023)
7.13.5 NightstaRx Key News & Latest Developments
8 Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity, Analysis
8.1 Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity, 2018-2029
8.2 Adeno-Associated Virus Vectors in Gene Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Adeno-Associated Virus Vectors in Gene Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Adeno-Associated Virus Vectors in Gene Therapy Supply Chain Analysis
10.1 Adeno-Associated Virus Vectors in Gene Therapy Industry Value Chain
10.2 Adeno-Associated Virus Vectors in Gene Therapy Upstream Market
10.3 Adeno-Associated Virus Vectors in Gene Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Adeno-Associated Virus Vectors in Gene Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 遺伝子送達/遺伝子治療薬のグローバル市場展望 2023年-2029年：ウイルス遺伝子送達システム、非ウイルス遺伝子送達システム
  • 遺伝子ベース先端治療医療のグローバル市場展望 2023年-2029年：ウイルス遺伝子送達システム、非ウイルス遺伝子送達システム
  • 遺伝子治療のグローバル市場（～2030年）：非ウイルス性ベクター、ウイルス性ベクター
  • 遺伝子治療のグローバル市場（2022年-2029年）：ウイルスベクター、非ウイルスベクター
  • 整形外科用細胞療法のグローバル市場展望 2023年-2029年：多血小板血漿注射、骨髄治療、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU4946 )"遺伝子治療におけるアデノ随伴ウイルスベクターのグローバル市場展望 2023年-2029年：血清型2（AVV2）、合成血清型、その他" (英文：Adeno-Associated Virus Vectors in Gene Therapy Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。